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The enrichment of putative CD44+/CD24−/low breast stem cell populations following 
exposure to ionizing radiation (IR) has been ascribed to their inherent radioresistance 
and an elevated frequency of symmetric division during repopulation. However, recent 
studies demonstrating radiation-induced phenotypic reprogramming (the transition 
of non-CD44+/CD24−/low cells into the CD44+/CD24−/low phenotype) as a potential 
mechanism of CD44+/CD24−/low cell enrichment have raised the question of whether a 
higher survival and increased self-renewal of existing CD44+/CD24−/low cells or induced 
reprogramming is an additional mode of enrichment. To investigate this question, 
we combined a cellular automata model with in  vitro experimental data using both 
MCF-10A non-tumorigenic human mammary epithelial cells and MCF-7 breast cancer 
cells, with the goal of identifying the mechanistic basis of CD44+/CD24−/low stem cell 
enrichment in the context of radiation-induced cellular senescence. Quantitative mod-
eling revealed that incomplete phenotypic reprogramming of pre-senescent non-stem 
cells (reprogramming whereby the CD44+/CD24−/low phenotype is conveyed, along with 
the short-term proliferation capacity of the original cell) could be an additional mode 
of enriching the CD44+/CD24−/low subpopulation. Furthermore, stem cell enrichment 
in MCF-7 cells occurs both at lower doses and earlier time points, and has longer 
persistence, than that observed in MCF-10A cells, suggesting that phenotypic plasticity 
appears to be less regulated in breast cancer cells. Taken together, these results sug-
gest that reprogramming of pre-senescent non-stem cells may play a significant role in 
both cancer and non-tumorigenic mammary epithelial populations following exposure 
to IR, a finding with important implications for both radiation therapy and radiation 
carcinogenesis.
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inTrODUcTiOn
Current dogma states that the recurrence of cancer in patients 
treated with radiation therapy is driven by the survival of 
radiation-resistant clonogens repopulating and replacing 
reproductively dead cells. This therapeutic resistance has been 
attributed to cells existing in hypoxic tumor regions where the 
lack of oxygen decreases the efficacy of radiation-induced cell 
killing. However, the contention that tumor-initiating or cancer 
stem cells, an inherently radioresistant population with increased 
DNA repair capacity, elevated expression of endogenous anti-
oxidant defenses, and a slower rate of cell division are the 
potential drivers of this phenomenon, has prompted a good deal 
of interest in targeting cancer stem cells (1). Cancer stem cells 
were originally identified in acute myeloid leukemia (2, 3) and 
since have been identified in solid tumors and cell lines, including 
breast (4), prostate (5), lung (6), glioblastoma (7), and squamous 
cell carcinoma of the head and neck (8).
Previous studies have demonstrated that putative stem cells 
in normal and malignant mammary tissues are characterized by 
a CD44+/CD24− phenotype (4, 9). Normal breast epithelial cells 
exhibiting the CD44+/CD24− phenotype express genes associ-
ated with stem cells and somatic cell reprogramming at higher 
levels, and can asymmetrically divide and differentiate giving 
rise to sub-phenotypes of basal and luminal cells (10). Some 
human mammary epithelial cell lines, most notably MCF-10A 
non-malignant cells have been demonstrated the propensity to 
recapitulate ductal morphogenesis in the humanized fat pads of 
mice (11), offering strong evidence for a stem-like/progenitor 
subpopulation. In vitro, MCF-10A cells spontaneously acquire 
the CD44+/CD24− phenotype via epithelial–mesenchymal tran-
sition (EMT) (12). In human breast cancers, the rare CD44+/
CD24−/low subpopulation shares properties with normal stem 
cells, including increased reproductive capacity and the abil-
ity to give rise to diverse cell lineages (4). CD44+/CD24− cells 
isolated from some human breast cancer cell lines (e.g., MCF-7) 
and patient tumors demonstrate many stem-cell like proper-
ties in vitro and in vivo (13). Importantly, the purified CD44+/
CD24− cells (mesenchymal-like cancer stem cell state) are able to 
generate heterogeneous populations that recreate the proportion 
of CD44+/CD24− and aldehyde dehydrogenase (ALDH) express-
ing cells (epithelial-like cancer stem cell state) present in the 
original cell lines (including MCF-7) (14), indicating that cellular 
plasticity enables breast cancer stem cells to transit between dif-
ferent phenotypes.
Radiation therapy is a common component of multimodal 
treatment designed to improve loco-regional control and overall 
survival in patients after breast-conserving surgery (15). After 
a single IR exposure (2–20 Gy γ-rays) we found the effective 
dose range for significantly enhancing the size of the stem cell 
pool differs between MCF-7 breast cancer cells and MCF-10A 
non-tumorigenic cells. Consistent with a previous report (16), 
following an acute radiation exposure of 10 Gy, the proportion of 
cells that are CD44+/CD24−/low in both cell lines is elevated and 
peaks around day 5 after IR. This enrichment has been attributed 
to a higher radioresistance of CD44+/CD24−/low cells and/or a 
switch from an asymmetric to symmetric type of division of 
CD44+/CD24−/low cells, which then produce two identical CD44+/
CD24−/low daughter cells leading to a relative and absolute 
increase in CD44+/CD24−/low subpopulation (17). In  addition, 
Lagadec et  al. demonstrated that radiation might reprogram a 
fraction of surviving non-stem committed cells (CCs) into the 
CD44+/CD24−/low phenotype in some breast cancer cells (16). 
Notably, in our in  vitro experiments, the fraction of senescent 
cells [cells that permanently withdraw from the cell cycle in 
response to diverse stress (18) (e.g., radiation-induced DNA 
damage), and can be identified by β-galactosidase (19)] increases 
and gradually dominates the population (~70%) during the 
10 days post 10 Gy IR in both cell lines. The enrichment of stem 
cells in the irradiated populations prompted us to investigate 
how the fate of irradiated cells, in particular those experienc-
ing IR-induced senescence, may influence cellular repopulation 
following exposure.
To explore the mechanistic basis for the elevated fraction 
of CD44+/CD24−/low phenotype observed in normal and breast 
cancer cell populations following irradiation, we combined 
in vitro experiments with a cellular automata (CA) model to test 
mechanistic alternatives. Comparing simulation results with 
in  vitro data demonstrated that neither (i) endowing normal 
and cancer stem cells with a lower radiosensitivity (i.e., a higher 
survival rate after irradiation), (ii) increasing the frequency of 
symmetric self-renewal division of stem cells, and (iii) increasing 
the rate of phenotypic reprogramming of surviving intact CCs 
to a full stem cell state, nor any combination of i, ii, and iii, were 
able to elevate the calculated stem cell percentage to match the 
observed percentage of CD44+/CD24−/low cells following an acute 
dose of 10 Gy.
Unsuccessful model fitting based on the aforementioned 
hypotheses turned our attention to the potential contribution of 
IR-induced pre-senescent CCs (non-stem cells with short-term 
proliferation capacity due to radiation damage) to the replenish-
ment of the stem cell pool through reprogramming. To this end, 
we considered two additional mechanisms: (iv) that, in addition 
to (iii), pre-senescent CCs can also be reprogramed to a stem 
cell state (i.e., CD44+/CD24−/low), albeit limited in this case to the 
remaining proliferative capacity they had before reprogramming 
(i.e., becoming pre-senescent SCs); or (v) all surviving CCs, 
whether pre-senescent, can have a potential to acquire a stem cell 
state with unlimited proliferative capacity. By fitting the model 
parameters in order to reproduce both the temporal dynamics 
of CD44+/CD24−/low cells and the proportion of senescent cells 
in the population during the first 10  days after irradiation, we 
found that allowing for pre-senescent CCs to have additional 
reprogramming capability as described in mechanisms (iv) can 
explain experimental results not reconcilable with mechanisms 
(i)– (iii) or (v). Furthermore, we observed that IR induced a high 
reprogramming rate that lasted longer in MCF-7 cells compared 
to MCF-10A cells.
In conclusion, our study suggests that IR-induced incomplete 
phenotypic reprogramming of pre-senescent non-stem cells in 
irradiated MCF-10A and MCF-7 cells might be a contributing 
factor to the enrichment of the CD44+/CD24−/low phenotype. 
Incomplete phenotypic reprogramming of pre-senescent CCs 
also gives rise to a heterogeneous stem cell pool consisting of 
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a fraction of cells that express the stem cell marker, but have a 
short-term proliferative potential. Finally, we find MCF-7 breast 
cancer cells to be more sensitive to acute, high-dose IR than 
MCF-10A non-tumorigenic mammary epithelial cells in terms 
of phenotypic reprogramming.
MaTerials anD MeThODs
cell culture
The human mammary epithelial, non-tumorigenic cell line MCF-
10A was purchased from ATCC and cultured in 1:1 Dulbecco’s 
modified essential medium (DMEM)/Ham’s F12 growth medium 
(Hyclone) supplemented with 5% fetal bovine serum (FBS), 
10 μg/mL insulin (Sigma), 20  ng/mL epidermal growth factor 
(EGF;Sigma), 0.5  μg/mL hydrocortisone (Sigma), 0.1  μg/mL 
cholera toxin (Sigma), and 1% glutamax (Life Technologies). The 
human mammary carcinoma cell line MCF-7 (kind gift from 
L. Chubb, CSU Animal Cancer Center) was grown in DMEM sup-
plemented with 10% FBS and 1% glutamax (Life Technologies). 
Cells were grown at 37°C in a humidified incubator at 5% CO2 
passaged 1–2 times per week.
Mammosphere assay
Sphere-forming assay was utilized to confirm stem-like proper-
ties of MCF-7 cells. Briefly, monolayer cultures were grown in 
low adherence dishes (Corning) at a low density in Mammocult 
sphere-forming media (Stem Cell Technologies). Limiting dilu-
tion assays were performed in 96-well plates comparing sorted 
CD44+/CD24−/low to bulk monolayer cell cultures. Spheres were 
allowed to form for 10 days, and spheres larger than 60 μm in 
diameter were scored (20).
irradiations
For clonogenic cell survival assays, cells were seeded 48 h prior to 
irradiation at a density of 3 × 105 cells per T25 flask. Monolayer 
cultures were irradiated in a Mark I Irradiator (J.L. Shepherd) 
utilizing a Cs-137 source at acute doses of 1, 2, 4, 5, 8, and 10 Gy 
or sham irradiated as a control. Following irradiation, cells were 
allowed to repair for 6 h and plated in triplicate at low density in 
100-mm cell culture plates (Greiner) containing 10 mL of culture 
medium. Cells were incubated for 12 days (MCF-7) or 16 days 
(MCF-10A), fixed in 100% ethanol, and stained with 0.05% crys-
tal violet solution. Colonies were scored based on the presence 
of 50 or more cells and scored independently by two individuals.
Flow cytometry analysis
All flow cytometry analyses were performed at the Colorado 
State University Animal Cancer Center on a Beckman Coulter 
CyAN ADP 9 Color analyzer running Summit Version 3.0 flow 
cytometry analysis software. Mammary epithelial stem cells were 
identified based on expression of CD44+/CD24−/low immunotype 
and stem-like properties were confirmed utilizing the ALDEfluro 
Assay (Stem Cell Technologies). Monolayer MCF-7 and MCF-
10A mammary epithelial cell cultures were stained for CD44 
and CD24 expression. Briefly, ~3 ×  105 cells were dissociated 
from cell culture surface using 0.25% Trypsin-EDTA, pelleted, 
washed, and re-suspended in 30  μL of Flow Cytometry wash 
buffer (1X PBS, 1% FBS, and 1% Penicillin/Streptomyocin). 
Six microliters of direct FITC-conjugated mouse monoclonal 
anti-human CD44 antibody (BD Pharmingen #555478) and 6 μL 
of direct PE-conjugated mouse monoclonal anti-human CD24 
antibody (BD Pharmingen #555428). Cells were then incubated 
for 30–60 min in the dark at 4°C. Following incubation, cells were 
pelleted and re-suspended in 500 μl of cold 1 × PBS and kept on 
ice until analysis. Analysis gates were established using cells from 
an unstained control and anti-mouse Ig,κ antibody capture beads 
(BD Pharmingen #552843).
identification of senescent cell Fraction
The fraction of senescent cells was determined via β-galactosidase 
staining. Cells were stained using β-galactosidase staining kit (Cell 
Signaling Technologies) and imaged on a confocal microscope at 
a 20× magnification utilizing a color camera. Cells were scored as 
positive based on the presence of blue pigmentation in the nuclei 
of adherent cells.
cellular automata Model
A CA model is used to simulate the dynamics and interactions of 
single cells in the growth of cell population (21). In a CA model, 
a system is represented as a collection of autonomous decision-
making agents (e.g., cells). Each agent is endowed some intrinsic 
state variables and behaves and interacts with each other and its 
external environment given a set of predefined rules. Stochastic 
interactions of single cells as well as with their external environ-
ment result in complex population dynamics. The CA framework 
can capture the interactive consequences of these dynamics while 
allowing for the examination of phenotypical and functional 
heterogeneity, such as stem cell biology.
The system is defined on a two-dimensional square lattice 
(L  ×  L lattice points) with periodic boundary conditions. As 
in silico cells live on a square lattice with (15 μm)2 grid points, 
a single migration step to a neighboring location is calibrated as 
15 or 21 μm in an 8-cell Moore neighborhood (21). Each lattice 
point can stay empty or be occupied by one cell. If a free lattice site 
is found within the Moore neighborhood of a cell, it can migrate 
with a probability pm, or divide to produce a new cell provided the 
maturation has been reached. A proliferative cell turns quiescent 
when it is completely surrounded by other cells but can re-enter 
the cell cycle when a neighboring free space is available. As per the 
stem cell hypothesis, stem cells reside at the top of the hierarchy 
and produce progenitor cells, which in turn give rise to CCs. For 
present purposes, a CC will refer to a non-stem cell. A stem cell 
is capable of dividing into two stem cells (symmetric division) 
with probability pS, or a stem cell and a CC with probability 1 − pS 
(asymmetrical division). The duplication of a non-senescent CC 
results in two CCs. A CC ceases to divide after some number 
of divisions, a phenomenon known as replicative senescence, 
or the Hayflick limit. The parameter ρ will refer to the number 
of remaining divisions a cell is capable of undergoing before it 
becomes senescent (the value ρ for a stem cell is, thus, ρ = ∞).
It has been found that normal and neoplastic non-stem cells 
can spontaneously convert to a stem-like state (22). In our model, 
CCs are eligible for reprogramming with probability pr. The rate 
of symmetric division (pS) and reprogramming rate (pr) were 
TaBle 1 | Model parameters and values.
Parameter Meaning Value reference
McF-10a McF-7
R MCF-10A or MCF-7 cell diameter 15 μm 15 μm (24)
V Cell migration speed 23.4 μm h−1 23.4 μm h−1 (25, 26)
c0 Initial cell cycle 17 h 24 h Fitting in vitro data
k Cell cycle inhibition coefficient 18 2.97 Fitting in vitro data
pd Spontaneous cell death rate of CC 0.004 CC−1day−1 0.02 CC−1day−1 Fitting in vitro data
ps Symmetric self-renewing division rate 10% SC (C) 10% (C) Fitting in vitro data
pr Phenotypic reprogramming rate 0.004 CC−1day−1 (C) 0.0017 CC−1day−1(C) Fitting in vitro data
pa Probability of permanent arrest 0.63 0.76 Fitting in vitro data
SF Overall survival rate following acute 10 Gy IR 0.0071 0.0031 Clonogenic assay
ρpsn Proliferation potential of pre-senescent cells 2–6 divisions 0–9 divisions Fitting in vitro data
C, control/sham irradiated with 0 Gy.
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estimated together in order to match the control frequency of 
CD44+/CD24−/low in both cell lines (Figure S1 in Supplementary 
Material). We referred a stem cell study by Tang et al. (11) in order 
to guess the initial value of pS.
To reproduce the population dynamics in vitro, we began with 
a fixed division cycling time in the CA model. However, the result-
ant growth curves were exponential, which could not explain 
the population dynamics in vitro, in which the cell proliferation 
rate decreases at later time points (Figure S2 in Supplementary 
Material). Indeed, cell population growth can be affected by the 
surrounding environment, such as (a) cell–cell contact inhibition 
(already implemented in the CA model), (b) nutrient availability, 
and (c) accumulation of toxic wastes. In our experiments, fresh 
culture medium was added to the cultures to ensure adequate 
cellular nutrition levels. However, no cell culture medium was 
removed following irradiation in order to prevent removal of 
potential reprogramming signals. Therefore, it is reasonable to 
presume that the decreasing proliferation rate of control growth 
(sham irradiated) is mostly a result of c. To depict this phenom-
enon simply, we introduced a cell cycle regulation mechanism 
implicitly as a function of cell population density:
 Cell cycle = 
*(population density)c0e
k
 
where c0 is the initial cycling time and k is the inhibition coef-
ficient. The values of c0 and k were estimated by matching the 
population dynamics in  vitro (Figure S3 in Supplementary 
Material). The estimated k value was smaller for MCF-7 cells 
than MCF-10A cells (Table 1) suggesting that breast cancer cells 
are more resistant to a stressful microenvironment than non-
cancerous cells, which belongs to one hallmark of cancer (evading 
growth suppressors) (23).
After radiation exposure, cells exhibit mitotic delay while 
attempting to repair radiation-induced DNA damage (27). 
Several studies have demonstrated that a large fraction of normal 
fibroblasts irradiated in G1-phase and reseeded after irradiation, 
do not re-enter the cell cycle but remained permanently arrested 
(28–30). Accordingly, we assumed that a cell either undergoes 
a permanent cycle arrest with a probability pa or experiences 
transient arrest for a randomly chosen time between 0 and 
10  days following radiation exposure. Cell survival probability 
after irradiation was determined via clonogenic assay (Figure S4 
in Supplementary Material). Some studies have demonstrated 
that MCF-7 cells undergo mostly IR-induced senescence instead 
of apoptosis (31–33). By day 10 of our experiment following a 
10 Gy single-dose IR, the senescent phenotype (SA-β-gal positive 
cells) had increased not only in ratio but also in number relative 
to day 0 within the proliferating cell population for both cell 
lines (Figures  2C,D; Figure S3 in Supplementary Material), 
which indicates the existence of cells in a pre-senescent state 
(have short-term proliferations before undergoing a senescent 
state). Therefore, we assigned to the pre-senescent CCs and 
pre-senescent SCs a temporal range of short-term proliferation 
potential ρpsn. The range of values for ρpsn was estimated by 
matching the irradiated population dynamics (Figure S3 in 
Supplementary Material) and senescent cell fractions in  vitro 
(Figures  2C,D). Cell cycle arrest has been found to prevent 
reprogramming (34,  35). Hence, a reprogramming rate pr =  0 
was applied to CCs in an arrested state and senescent cells.
A diagram of the simulation process and decisions at the cell 
level is shown in Figure S5 in Supplementary Material. The model 
parameters and their values are summarized in Table 1.
resUlTs
McF-10a and McF-7 Populations show 
Different Dose ranges Over Which There 
is substantial cD44+/cD24−/low cell 
Fraction Modification
In MCF-10A cells, at day 5 after irradiation with a single dose 
of 5 Gy or lower, the fraction of CD44+/CD24−/low cells showed 
no difference compared to control (Figure 1A); whereas a dose 
as low as 2 Gy induced an enrichment of the CD44+/CD24−/low 
subpopulation among MCF-7 cells (Figure 1B) (20). When the 
IR dose increased to 20  Gy, a tremendously high enrichment 
of CD44+/CD24−/low subpopulation appeared in MCF-10A cells 
(Figure  1A). By contrast, a 20  Gy single dose did not further 
increase the fraction of CD44+/CD24−/low subpopulation in 
MCF-7 cells (Figure  1B). Presumably, the mechanisms for 
regulating the CD44+/CD24−/low cells are not easily altered in 
the non-tumorigenic population vs. cancer cells, suggesting a 
potentially pivotal role for this enrichment in tumor re-growth 
following radiation therapy.
FigUre 1 | radiation-induced enrichment of cD44+/cD24−/low putative stem cells in (a) McF-10a cells and (B) McF-7 cells in vitro is in a dose 
dependent manner (mean ± sD; n = 3).
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enrichment of cD44+/cD24−/low Phenotype 
in McF-10a and McF-7 cells May not 
Derive Purely from intact surviving cells
To evaluate the mechanistic basis of IR-induced enrichment of 
CD44+/CD24−/low phenotype in MCF-10A and MCF-7 cells, we 
tested the following hypothesis: (i) low radiosensitivity of stem 
cells (maximum tested: 100% survival after radiation exposure), 
(ii) increased symmetric division frequency (maximum tested: 
100% per stem cell division) of stem cells, and (iii) increased 
reprogramming frequency of undamaged cycling CCs (maxi-
mum tested: 100% per intact CC per day). The resulting frac-
tions of senescent cells were similar to one another for the three 
mechanisms, which roughly reproduced the observed dynamics 
of state with a decreased reproductive capacity positive cell stain-
ing in vitro (Figures 2C,D). Surprisingly, however, neither of the 
three mechanisms alone were able to produce the observed high 
percentage of CD44+/CD24−/low cells observed in either cell line 
(Figures 2A,B), nor were combinations of any two mechanisms 
able to generate the high fraction of stem cells especially at day 
5 after exposure to 10 Gy (data not shown). Combining all three 
mechanisms (e.g., >50% survival rate of SCs, 100% symmetric 
division rate, and 100% reprogramming rate of non-arrested 
intact CCs) produced a comparable fraction of CD44+/CD24−/low 
in MCF-10A cells (Figure 2A) but not in MCF-7 cells. However, 
the resulting ratio of senescent cells (~43% in silico) was smaller 
than that observed (67% in  vitro; Figure  2C) at day 10 after 
irradiation, which makes it less likely that the possibility of the 
combination of above three mechanisms is a major force in 
enriching the stem cell pool.
radiation-induced incomplete 
Phenotypic reprogramming of  
Pre-senescent non-stem cells appears 
More likely To Be an additional Mode 
of enriching cD44+/cD24−/low cells
The above disparities led us to consider alternative explanations; 
specifically, phenotypic reprogramming of pre-senescent non-
stem cells. In the latter case, it has been demonstrated that cellular 
senescence is not a limit to reprogramming and that age-related 
cellular physiology is reversible (36). Nevertheless, it is unknown 
to what extent reproductive potential can be regained by the 
reprogramming of senescent cells, e.g., 0–100%. Instead of testing 
the recovery of proliferative capacity in a quantitative manner, we 
simply assume that reprogramming of a pre-senescent CC can be 
either (iv) incomplete (i.e., pre-senescent CCs are reprogramed to 
pre-senescent SCs but inherit the remaining proliferative poten-
tial) or (v) complete (i.e., pre-senescent CCs are reprogramed to 
SCs and reacquire unlimited proliferative potential). Simulation 
results showed that both hypotheses (iv) and (v) could success-
fully reproduce a comparable ratio of CD44+/CD24−/low cells 
observed 10 days after 10 Gy (Figures 2E,F). However, following 
hypothesis (v), at day 10 after 10  Gy, the fraction of senescent 
cells in simulations was lower than observed in vitro in both cell 
lines (Figures  2G,H). Considering these findings together, the 
enrichment of CD44+/CD24−/low phenotype in MCF-10A and 
MCF-7 cells is more likely driven to a large extent by incomplete 
phenotypic reprogramming. As a consequence, the enriched stem 
cell pool would be mixed with a fraction of stem cells that have 
a short-term proliferative potential (Figure  3). Therefore, the 
signature of CD44+/CD24−/low is no longer accurate for presenting 
the overall “stemness” of the irradiated cell population.
The ir-induced reprogramming events 
Persist longer in McF-7 Breast cancer 
cells than in McF-10a non-Tumorigenic 
Mammary epithelial cells
During the process of parameter fitting in order to reproduce the 
dynamics of the CD44+/CD24−/low subpopulation after a 10  Gy 
single-dose IR, we found differential changes in the kinetics 
of reprogramming between MCF-10A and MCF-7 cells. For 
MCF-10A cells, the fitted reprogramming rate only transiently 
increased to 0.09 per CC (intact or pre-senescent) per day for 38 h 
during days 3–5 after IR (Figure 2E). By contrast, the reprogram-
ming rate of MCF-7 cells increased to 0.08 per CC (intact or pre-
senescent) per day immediately following the radiation exposure 
and through day 4 (Figure 2F), then decreased to 0.0198 per CC 
FigUre 2 | The comparisons between model simulation results (mean ± sD; n = 10 simulations) of applying hypothesis (i), (ii), or (iii) (alone 
or in combinations) and in vitro data (mean ± sD; n = 3) on the (a) % of cD44+/cD24−/low cells in McF-10a cells and (B) McF-7 cells; and the 
(c) % of sa-β-gal positive cells in McF-10a cells and (D) McF-7 cells. The comparisons between simulation results of applying hypothesis (iv) or (v) 
and in vitro data on the (e) % of CD44+/CD24−/low cells in MCF-10A cells and (F) MCF-7 cells; and the (g) % of SA-β-gal positive cells in MCF-10A cells and 
(h) MCF-7 cells. Hyp stands for hypothesis in the figure legends. Best fitting for MCF-10A cells under Hyp (iv) [corresponding to (e,g)]: reprogramming rate 
(pr) increases to 0.09 per CC (intact or pre-senescent) per day for 38 h during days 3–5 after irradiation. Best fitting for MCF-7 cells under Hyp 
(iv) [corresponding to (F,h)]: reprogramming rate (pr) increases to 0.08 per CC (intact or pre-senescent) per day during first 4 days after irradiation, then 
decreases to 0.0198 for the following time points.
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FigUre 3 | Following the hypothesis of ir-induced incomplete phenotypic reprogramming, the model simulation predicted the proportions of intact 
(solid colors) vs. pre-senescent (striped colors) cD44+/cD24−/low sub-populations for (a) McF-10a cells (corresponding to hyp (iv) curve in Figure 2e) 
and (B) McF-7 cells [corresponding to hyp (iv) curve in Figure 2F]. Data points are plotted on a log scale.
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(intact or pre-senescent) per day although it remained elevated 
relative to the control (0.0017 per CC per day; Table 1).
Taken together, these results demonstrate that the equi-
librium of CD44+/CD24−/low cells is more tightly regulated in 
non-tumorigenic than cancer cells in response to an acute 10 Gy 
dose of radiation; deregulation of this process may play a role in 
carcinogenesis by providing an advantage to cells that are more 
capable of being reprogramed to a stem-like state.
DiscUssiOn anD cOnclUsiOn
Maintenance of the pool of putative stem cells requires a finely 
tuned balance between self-renewal, differentiation, and recruit-
ment (dedifferentiation or reprogramming). Alterations in the 
equilibrium of maintaining adult stem cells can affect tissue 
homeostasis as well as cancer progression and carcinogenesis. 
Radiation-induced enrichment of stem cells has been attributed 
to advanced DNA-damage repair mechanisms (37, 38), enhanced 
survival and subsequent expansion of the (more resistant) 
quiescent fraction of stem cells as they return to a proliferative 
state (39), a switch from asymmetric to symmetric stem cell self-
renewal division (40), and an increased frequency of reprogram-
ming (16, 41). For this study of MCF-10A and MCF-7 cells, a CA 
model was used to test several hypotheses, including (i) lower 
radiosensitivity (or higher survival rate) of SCs, (ii) increased 
symmetric division frequency, (iii) increased phenotypic repro-
gramming frequency of intact non-arrested CCs, (iv) incomplete 
reprogramming of pre-senescent CCs to pre-senescent SCs with 
short-term proliferative capacity, and (v) complete reprogram-
ming of pre-senescent CCs to SCs with unlimited proliferative 
capacity. Our simulation results showed that incomplete phe-
notypic reprogramming (hypothesis iv) could reproduce the 
dynamics of CD44+/CD24−/low cells, as well as the fraction of 
SA-β-gal positive senescent cells in vitro for both cell lines (20). 
Following IR-induced incomplete phenotypic reprogramming, 
the resultant stem cell pool is expected to be heterogeneous, 
with the reprogramed cells expressing putative stem cell markers 
(CD44+/CD24−/low), but possessing only short-term proliferation 
potential. Therefore, such heterogeneity would suggest that a 
large stem cell pool may not necessarily implicate a strong popu-
lation re-growth potential if a high proportion of stem cells have 
a short-term proliferation potential. To test this hypothesis, we 
plan to purify the IR-enriched stem cells, and then compare their 
colonization and mammosphere formation capacity with unir-
radiated stem cells. It has been previously demonstrated that in 
primary breast xenografts, CD44+/CD24− and ALDH expressing 
cells identified overlapping, but non-identical cell populations, 
both of which were able to initiate tumors in NOD/SCID mice 
(42). Importantly, ALDH+ and CD44+/CD24−/low cells can transit 
between each other via EMT and mesenchymal– epithelial transi-
tion (MET) (14), highlighting the necessity of using both CD44/
CD24 and ALDH for measuring changes in stem cell pool size 
after irradiation. Additionally, co-staining with β-gallactosidase 
will determine whether senescent cells express stem cell markers.
In our previous study (40), we showed that radiation-induced 
accelerated proliferation of glioma stem cells may contribute to 
their increased frequency in recurrent glioblastoma. To our knowl-
edge, IR-induced proliferation of CD44+/CD24−/low compartments 
in vitro lacks experimental support. Indeed, Wicha and colleagues 
(14) have shown that the CD44+/CD24− signature is associated 
with a low proliferative capacity. However, if we assume expansion 
of CD44+/CD24−/low cellular compartments via accelerated sym-
metric division after radiation exposure, some would be expected 
to localize adjacently, a prediction that could be confirmed by 
co-localization of CD44+/CD24−/low cells after irradiation.
Phenotypic plasticity appears to be more tightly regulated in 
MCF-10A non-tumorigenic mammary epithelial cells in response 
to an acute radiation exposure of 10  Gy or lower. In contrast, 
relatively high plasticity can be induced in MCF-7 breast cancer 
cells by a lower dose if IR (i.e., ≤10 Gy). When dose is increased 
to 20 Gy, an elevated level of cellular reprogramming might be 
evoked in the normal breast epithelium cells, resulting in enrich-
ment of stem cell pools. The reprogramming capacity of breast 
cancer cells seems to reach a plateau at 10 Gy, beyond which no 
significant increase in the percentage of CD44+/CD24−/low cells 
is observed. Notably, the IR-induced high rate of phenotypic 
reprogramming lasted longer in MCF-7 cells than MCF-10A 
cells, where it appears only transiently.
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Molecular mechanisms governing reprogramming in the 
 context of radiation therapy remain elusive, although our recent 
study demonstrated that IR-induced stem cell enrichment is 
telomerase dependent (20). Genomic analysis of cell populations 
at the time points corresponding to the modeling done here may 
strengthen the case for IR-induced reprogramming. Specifically, 
the difference in reprogramming response with regard to non-
cancer vs. cancer cells could reflect deregulation of anti-tumor 
molecular machinery such as occurs during the process of car-
cinogenesis, which may also tightly regulate the ability of cells to 
be reprogramed, providing fertile ground to explore new mecha-
nisms driving this disease. Wicha and colleagues suggested HER2 
as a potential driver of cancer stem cells in luminal breast cancers 
(43). They showed that knockdown of HER2 abrogates MCF-7 
cells tumorsphere formation. According to a study by Chung et al. 
(44), HER2 can induce stem cell marker expression and SLUG 
upregulation that promote the EMT phenotype in MCF-7 cells. 
Indeed, HER2 is overexpressed in MCF-7 cells following IR (45). 
Quantitative measurement of HER2 expression levels and kinetics 
in senescent normal epithelial and breast cancer cells may provide 
invaluable information on the role of senescent cells in regulating 
cellular population dynamics after ionizing radiation exposure.
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FigUre s1 | simulation reproducing the fraction of cD44+/cD24-/low cells 
in the control 494 condition (sham irradiation) for (a) McF-10a cells and 
(B) McF-7 cells (mean ± sD; n = 10 simulations).
FigUre s2 | Unsuccessful fitting of cell population dynamics by applying 
reported 496 average cell cycle time in vitro for both (a) McF-10a cells 
(fitting curve: average cell cycle time 20 497 hours (46); mean ± sD; n = 
10 simulations) and (B) McF-7 cells (fitting curve: average cell cycle time 
498 26.8 hours (47); mean ± sD; n = 10 simulations).
FigUre s3 | simulation reproducing population dynamics with sham 
irradiation or a 10 500 gy single-dose ir for (a) McF-10a cells and (B) 
McF-7 cells (mean ± sD; n =10 simulations). Hyp 501 stands for hypothesis 
in the figure legends.
FigUre s4 | clonogenic survival fraction of (a) McF-10a cells and (B) 
McF-7 cells 503 and fitted curve with linear quadratic equation.
FigUre s5 | Diagram of the simulation process and decisions on the cell 
level.
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